4.8 Article

The Role of Conformational Ensembles in Ligand Recognition in G-Protein Coupled Receptors

Journal

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 133, Issue 33, Pages 13197-13204

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ja205313h

Keywords

-

Funding

  1. Boehringer-Ingelheim
  2. National Science Foundation through TeraGrid resources [TG-MCB110030]

Ask authors/readers for more resources

G-protein coupled receptors (GPCRs) are allosteric membrane proteins mediating cellular signaling. GPCRs exhibit multiple inactive and active conformations, and the population balance between these conformations is altered upon binding of signaling molecules (or ligands). However, the nature of the conformational ensemble or the mechanism of the conformational transitions is not well understood. We present a multiscale computational approach combining a coarse-grained discrete conformational sampling method with fine-grained molecular dynamics investigating the effect of various ligands binding on the ensemble of conformations sampled by human beta 2-adrenergic receptor (beta 2AR). We show that the receptor, in the absence of any ligand, samples an extensive conformational space that includes breathing of the orthosteric ligand binding site and shear motion of the transmembrane helices 5 and 6 against the other helices. The shear motion is similar to the reorganization of the intracellular regions of TM3, TM5, and TM6 observed in the crystal structure of the active state of GPCRs. The binding of agonist norepinephrine or partial agonist salbutamol leads to the selection of a subset of conformations including active and inactive state conformations, while inverse agonist carazolol selects only inactive state conformations. The dynamics of water observed during the simulations provides an explanation for the conformational changes observed in the solution-based fluorescence spectroscopic measurements on agonist activated beta 2AR, which could not be explained by the agonist bound beta 2AR crystal structure. This study shows that the receptor activation depends on both the low energy states and the range of the conformations sampled by the receptor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule

Christofer S. Tautermann, Florian Binder, Frank H. Buettner, Christian Eickmeier, Dennis Fiegen, Ulrike Gross, Marc A. Grundl, Ralf Heilker, Scott Hobson, Stefan Hoerer, Andreas Luippold, Volker Mack, Florian Montel, Stefan Peters, Supriyo Bhattacharya, Nagarajan Vaidehi, Gisela Schnapp, Sven Thamm, Markus Zeeb

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Chemistry, Multidisciplinary

Dynamics of Co-translational Membrane Protein Integration and Translocation via the Sec Translocon

Michiel J. M. Niesen, Matthew H. Zimmer, Thomas F. Miller

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Chemistry, Physical

Water Dynamics Around Proteins: T- and R-States of Hemoglobin and Melittin

Marco Pezzella, Krystel El Hage, Michiel J. M. Niesen, Sucheol Shin, Adam P. Willard, Markus Meuwly, Martin Karplus

JOURNAL OF PHYSICAL CHEMISTRY B (2020)

Article Biology

Water orientation and dynamics in the closed and open influenza B virus M2 proton channels

Martin D. Gelenter, Venkata S. Mandala, Michiel J. M. Niesen, Dina A. Sharon, Aurelio J. Dregni, Adam P. Willard, Mei Hong

Summary: By using solid-state NMR spectroscopy and molecular dynamics simulations, researchers found that water molecules in the channel of the influenza B M2 protein exhibit faster dynamics and higher orientational order in the open state compared to the closed state, establishing the necessary water network structure for proton hopping.

COMMUNICATIONS BIOLOGY (2021)

Article Biophysics

Force transduction creates long-ranged coupling in ribosomes stalled by arrest peptides

Matthew H. Zimmer, Michiel J. M. Niesen, Thomas F. Miller

Summary: Force-sensitive arrest peptides stall protein biosynthesis by inhibiting the ribosome, and can be restarted by a pulling force. Essential amino acids far from the peptidyl transferase center play a key role in responding to applied force. The mechanism of force-induced restart in relation to these amino acids remains unknown.

BIOPHYSICAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein

Rohit Suratekar, Pritha Ghosh, Michiel J. M. Niesen, Gregory Donadio, Praveen Anand, Venky Soundararajan, A. J. Venkatakrishnan

Summary: The highly contagious Delta variant of SARS-CoV-2 has become a prevalent strain globally. This study provides a systematic analysis of mutations in all the SARS-CoV-2 proteins and identifies six highly prevalent missense mutations in the Delta variant's viral life cycle-associated proteins. The study also reveals that the Delta variant has a more diverse repertoire of mutations across countries compared to the previously dominant Alpha variant.

MOLECULAR SYSTEMS BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy

Arin Nam, Atish Mohanty, Supriyo Bhattacharya, Sourabh Kotnala, Srisairam Achuthan, Kishore Hari, Saumya Srivastava, Linlin Guo, Anusha Nathan, Rishov Chatterjee, Maneesh Jain, Mohd W. Nasser, Surinder Kumar Batra, Govindan Rangarajan, Erminia Massarelli, Herbert Levine, Mohit Kumar Jolly, Prakash Kulkarni, Ravi Salgia

Summary: This study developed a mathematical approach based on game theory to model the response of non-small cell lung cancer cells to cisplatin treatment. The findings suggest that dynamic interactions and group behavior play a role in drug resistance, with tolerant cells displaying a 'persister-like' behavior and educating sensitive cells to evade chemotherapy. Furthermore, intermittent chemotherapy may be a better treatment strategy to reduce the emergence of tolerant cells in lung cancer.

BIOMOLECULES (2022)

Article Medicine, General & Internal

Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records

Michiel J. M. Niesen, Colin Pawlowski, John C. O'Horo, Doug W. Challener, Eli Silvert, Greg Donadio, Patrick J. Lenehan, Abinash Virk, Melanie D. Swift, Leigh L. Speicher, Joel E. Gordon, Holly L. Geyer, John D. Halamka, A. J. Venkatakrishnan, Venky Soundararajan, Andrew D. Badley

Summary: This study evaluated the safety of the third dose of FDA-approved COVID-19 mRNA vaccines. The findings suggest that although the third dose is associated with an increased reporting of low-severity adverse events, the risk of severe adverse events remains comparable to the standard two-dose regime. This study provides evidence for the safety of third vaccination doses in eligible individuals for booster vaccination.

JAMA NETWORK OPEN (2022)

Article Cell Biology

Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest

Praveen Anand, Patrick J. Lenehan, Michiel Niesen, Unice Yoo, Dhruti Patwardhan, Marcelo Montorzi, A. J. Venkatakrishnan, Venky Soundararajan

Summary: Acute cardiac injury has been observed in some COVID-19 patients, and it is hypothesized that molecular mimicry may trigger an autoimmune inflammatory reaction. This study investigates the presence of similar peptides in the SARS-CoV-2 proteome as those found in human heart proteins. The findings suggest that viral variants with peptides identical to human cardiac proteins should be further investigated for their role in cardiac inflammation.

CELL DEATH DISCOVERY (2022)

Article Medicine, General & Internal

Addressing Drug Resistance in Cancer: A Team Medicine Approach

Prakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, Sharad Singhal, Linlin Guo, Sravani Ramisetty, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti Malhotra, Naveen Gupta, Pauline Kim, Razmig Babikian, Swapnil Rajurkar, Shanmuga Subbiah, Tingting Tan, Danny Nguyen, Amartej Merla, Sudarsan Kollimuttathuillam, Tanyanika Phillips, Peter Baik, Bradford Tan, Pankaj Vashi, Sagun Shrestha, Benjamin Leach, Ruchi Garg, Patricia L. Rich, F. Marc Stewart, Evan Pisick, Ravi Salgia

Summary: Drug resistance is a major obstacle in cancer treatment. However, the use of a 'Team Medicine' approach and the development of new therapeutic strategies, such as intermittent therapy, based on eco-evolutionary principles, have shown promising results. Incorporating these strategies into clinical protocols can enhance the precision of personalized medicine.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Immunology

On the Origins of Omicron's Unique Spike Gene Insertion

A. J. Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Rohit Suratekar, Bharathwaj Raghunathan, Michiel J. M. Niesen, Venky Soundararajan

Summary: The emergence of the heavily mutated Omicron variant of SARS-CoV-2 has raised global public health concerns. The Spike protein of Omicron carries 26 unique amino acid mutations. One of these mutations, ins214EPE, has not been observed in any other SARS-CoV-2 variant and may have been acquired through template switching. This template-switching event could involve other human coronaviruses that infect the same host cells as SARS-CoV-2 or a human transcript expressed in an Omicron-infected host cell.

VACCINES (2022)

Article Medicine, General & Internal

A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer

Sravani Ramisetty, Prakash Kulkarni, Supriyo Bhattacharya, Arin Nam, Sharad S. Singhal, Linlin Guo, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti Malhotra, Evan Pisick, Shanmuga Subbiah, Swapnil Rajurkar, Erminia Massarelli, Ravi Salgia, Atish Mohanty

Summary: Translational research in medicine involves collaboration between scientists from different disciplines to apply knowledge from basic sciences to clinical practice. This approach, known as 'Team Medicine', focuses on addressing specific medical goals through partnership between basic science researchers and clinicians. Using cisplatin resistance in non-small cell lung cancer (NSCLC) as an example, this study demonstrates how a 'Team Science' approach was used to identify a previously approved compound that can alleviate cisplatin resistance in NSCLC. It also highlights the potential of a 'Team Medicine' approach in understanding resistance mechanisms and developing strategies to overcome drug resistance in NSCLC.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, Research & Experimental

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection

Arjun Puranik, Patrick J. Lenehan, Eli Silvert, Michiel J. M. Niesen, Juan Corchado-Garcia, John C. O'Horo, Abinash Virk, Melanie D. Swift, Joel E. Gordon, Leigh Lewis Speicher, Holly L. Geyer, Walter Kremers, John Halamka, Andrew D. Badley, A. J. Venkatakrishnan, Venky Soundararajan

Summary: The mRNA-1273 and BNT162b2 vaccines provide strong protection against symptomatic SARS-CoV-2 infection. However, their effectiveness was reduced during July-September and mRNA-1273 had a lower risk of breakthrough infection compared to BNT162b2.
Article Medicine, Research & Experimental

FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a mufti-state health system

Colin Pawlowski, Patrick Lenehan, Arjun Puranik, Vineet Agarwal, A. J. Venkatakrishnan, Michiel J. M. Niesen, John C. O'Horo, Abinash Virk, Melanie D. Swift, Andrew D. Badley, John Halamka, Venky Soundararajan

Summary: The study analyzed the effectiveness of BNT162b2 and mRNA-1273 vaccines in preventing COVID-19 in a real-world setting, and found that both vaccines were highly effective in reducing SARS-CoV-2 infection rates and lowering the burden of COVID-19 on the healthcare system.
Meeting Abstract Biotechnology & Applied Microbiology

Use of Click-Chemistry to Make Bivalent Antibodies for Redirection of T Cells: Proof of Concept in an In Vitro HIV Model

Shirley Li, Maciej Kujawski, Lin Li, Harry Li, Supriyo Bhattacharya, Vaidehi Nagarajan, Paul Yazaki, Pamela J. Bjorkman, John Zaia, John E. Shively

MOLECULAR THERAPY (2020)

No Data Available